Pharming Group (OTCMKTS:PHGUF – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $1.07 and last traded at $1.07, with a volume of 0 shares. The stock had previously closed at $1.07.
Pharming Group Stock Performance
The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.33 and a current ratio of 4.06. The firm’s fifty day simple moving average is $1.17 and its 200 day simple moving average is $1.17.
Pharming Group Company Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Recommended Stories
- Five stocks we like better than Pharming Group
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Comprehensive PepsiCo Stock Analysis
- There Are Different Types of Stock To Invest In
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.